# Peijia Medical Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/peijia-medical-co

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.peijiamedical.com
- Total disclosed funding: $100M
- Latest round: Series C (Nov 6, 2019)
- Investors on record: 5

## About

Established in 2012 and based in Suzhou, China, Peijia Medical Co., Ltd. operates as a medical device developer focuses on the treatment of heart disease medical equipment research and development. It has applied more than 400 patents. The company has established innovation centers and R&D centers in the United States, Canada, and France, and has built medical device production and R&D bases that meet GMP standards in Shanghai and Suzhou. In November 2019, Peijia Medical Co., Ltd. raised USD 100 million in series C funding. In 2020, it was listed on the Hong Kong Stock Exchange.

The company develops and produces high-end medical devices in the field of structural heart disease and cerebrovascular intervention. Its products include aortic valve, mitral valve, tricuspid valve and surgical accessories, cerebrovascular intervention bleeding, ischemia, etc.

The company generates revenue by developing aortic valve TAVI, cardiac drug-eluting stents and intracranial coils.

## Funding rounds

- Series C, Nov 6, 2019, $100M — Lilly Asia Ventures, CS Capital, Grand Flight Investment, CCT Fund Management, MPC
- Series B, Nov 16, 2018 — Lilly Asia Ventures
- Series A, Apr 8, 2016 — MPC

## Investors

- MPC — Series A, Series C
- Lilly Asia Ventures (https://capitalatlas.ai/funds/lilly-asia-ventures) — Series B, Series C
- CS Capital — Series C
- Grand Flight Investment (https://capitalatlas.ai/funds/grand-flight-investment) — Series C
- CCT Fund Management — Series C